Generic Cos. Must Face IP Claims Over Novartis Blockbuster
A Delaware federal judge on Friday cleared Novartis Pharmaceuticals Corp. to proceed with infringement litigation against a pair of companies aiming to sell generic versions of its blockbuster cardiovascular drug Entresto....To view the full article, register now.
Already a subscriber? Click here to view full article